1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
5.1.1.2. Increased Focus on Drug Development
5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
5.1.2. Restraints
5.1.2.1. Increased Cost of Drug Development and Clinical Trials
5.1.3. Opportunities
5.1.3.1. Outsourcing of Clinical Trial Activity
5.1.3.2. Increased Focus on Generics and Biologics
5.1.3.3. Regulatory Approvals in Emerging Markets
5.1.4. Challenges
5.1.4.1. Logistics Challenges across Nations
5.2. Cumulative Impact of COVID-19

6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
6.1. Introduction
6.2. BA/BE Studies
6.3. Phase I
6.4. Phase II
6.5. Phase III
6.6. Phase IV

7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector
7.1. Introduction
7.2. Clinical Trial Logistics and Distributions
7.3. Clinical Trial Manufacturing Services
7.4. Clinical Trial Supply Chain Management

8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area
8.1. Introduction
8.2. Blood Disorders
8.3. Digestive System Diseases
8.4. Infectious and Immune System Diseases
8.5. Neurological and Mental Disorders
8.6. Oncology

9. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Almac Group
13.2. Bilcare Limited
13.3. Biocair International Limited
13.4. Catalent, Inc.
13.5. Clinigen Group PLC
13.6. DHL International GmbH by Deutsche Post AG
13.7. Eurofins Scientific SE
13.8. FedEx Corporation
13.9. Infosys Limited
13.10. KLIFO A/S
13.11. Lonza Group
13.12. Marken
13.13. Metrics Contract Services by Mayne Pharma group
13.14. Movianto
13.15. N-Side
13.16. Parexel International Corporation
13.17. PRA Health Sciences, Inc.
13.18. Seveillar Clinical Trial Supplies Pvt. Ltd.
13.19. SIRO Clinpharm Private Limited
13.20. Thermo Fisher Scientific, Inc.
13.21. UDG Healthcare PLC
13.22. World Courier Management Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2020 VS 2026 (%)
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2020 VS 2026 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2026
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, 2018-2026 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, 2018-2026 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2020 VS 2026 (%)
FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2026
FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (%)
FIGURE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2026
FIGURE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. QATAR CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. RUSSIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. SAUDI ARABIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. SOUTH AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. SPAIN CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. UNITED KINGDOM CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: SCORES
TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RANKING
TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: LICENSE & PRICING

Companies Mentioned

Almac Group
Bilcare Limited
Biocair International Limited
Catalent, Inc.
Clinigen Group PLC
DHL International GmbH by Deutsche Post AG
Eurofins Scientific SE
FedEx Corporation
Infosys Limited
KLIFO A/S
Lonza Group
Marken
Metrics Contract Services by Mayne Pharma group
Movianto
N-Side
Parexel International Corporation
PRA Health Sciences, Inc.
Seveillar Clinical Trial Supplies Pvt. Ltd.
SIRO Clinpharm Private Limited
Thermo Fisher Scientific, Inc.
UDG Healthcare PLC
World Courier Management Inc.